Permanent atrial fibrillation impairs the function of circulating endothelial progenitor cells

References

• Camm AJ, Kirchhof P, Lip GY, et al.; European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31(19):2369–2429.
   PubMed Web of Science ®Google Scholar
• Im S, Chun KJ, Park SJ, et al. Long-term prognosis of paroxysmal atrial fibrillation and predictors for progression to persistent or chronic atrial fibrillation in the Korean population. Korean Med Sci. 2015;30:895–902.
   Google Scholar
• Krishnamoorthy S, Lim SH, Lip GY. Assessment of endothelial (dys)function in atrial fibrillation. Ann Med. 2009;41:576_590.
   PubMed Web of Science ®Google Scholar
• Sukmawati D, Tanaka R. Introduction to next generation of endothelial progenitor cell therapy: a promise in vascular medicine. Am J Transl Res. 2015;7(3):411–421.
   PubMed Web of Science ®Google Scholar
• Freestone B, Chong AY, Nuttall S, et al. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationshipto plasma von willebrand factor and soluble E-selectin levels. Thromb Res. 2008;122:85–90.
   PubMed Web of Science ®Google Scholar
• Skalidis EI, Zacharis EA, Tsetis DK, et al. Endothelial cell function during atrial fibrillation and after restoration of sinus rhythm. Am J Cardiol. 2007;99:1258–1262.
   PubMed Web of Science ®Google Scholar
• Padfield GJ, Tura-Ceide O, Freyer E, et al. Endothelial progenitor cells, atheroma burden and clinical outcome in patients with coronary artery disease. Heart. 2013;99:791–798.
   PubMed Web of Science ®Google Scholar
• Makino H, Miyamoto Y, Kikuchi-Taura A, et al. Decreased levels of circulating CD34+ cells are associated with coronary heart disease in Japanese patients with type 2 diabetes. Diabetes Invest. 2015;6:473–478.
   PubMed Web of Science ®Google Scholar
• Giannotti G, Doerries C, MocharlaP S, et al. Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension relation to endothelial dysfunction. Hypertension. 2010;55:1389–1397.
   PubMed Web of Science ®Google Scholar
• Berezin AE, Kremzer AA. Circulating endothelial progenitor cells as markers for severity of ischemic chronic heart failure. J Card Fail. 2014;20:438–447.
   PubMed Web of Science ®Google Scholar
• Li YF, Ren LN, Guo G, et al. Endothelial progenitor cells in ischemic stroke: an exploration from hypothesis to therapy. J Hematol Oncol. 2015;8:33.
   PubMed Web of Science ®Google Scholar
• Camm AJ, Kirchhof P, Lip GY, et al. European heart rhythm association; european association for cardio‑thoracic surgery; ESC committee for practice guidelines: guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the european society of cardiology (ESC). Europace. 2012;12:1360‑1420.
   Web of Science ®Google Scholar
• Tan Q, Qiu LG, Li GP, et al. Transplantation of healthy but not diabetic outgrowth endothelial cells could rescue ischemic myocardium in diabetic rabbits.. Scandi J Clin Lab Invest. 2010;70(5):313–321.
   PubMed Web of Science ®Google Scholar
• Chavakis E, Urbich C, Dimmeler S. Homing and engraftment of progenitor cells: a prerequisite for cell therapy. J Mol Cell Cardio. 2008;l(45):514.
   Web of Science ®Google Scholar
• Fadini GP, Losordo D, Dimmeler S. Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res. 2012;110:624.
   PubMed Web of Science ®Google Scholar
• Lee PS, Poh KK. Endothelial progenitor cells in cardiovascular diseases. World J Stem Cells. 2014;6:355–366.
   PubMedGoogle Scholar
• Berezin AE, Kremzer AA, Martovitskava A, et al. Pattern of endothelial progenitor cells and apoptotic endothelial cell-derived microparticles in chronic heart failure patients with preserved and reduced left ventricular ejection fraction. EBioMedicine. 2016;4:86–94.
   PubMed Web of Science ®Google Scholar
• Siu CW, Watson T, Lai WH, et al. Relationship of circulating endothelial progenitor cells to the recurrence of atrial fibrillation after successful conversion and maintenance of sinus rhythm. Europace. 2010;12:517–521.
   PubMed Web of Science ®Google Scholar
• Suh W, Kim KL, Choi JH, et al. C-reactive protein impairs angiogenic functions and decreases the secretion of arteriogenic chemo-cytokines in human endothelial progenitor cells. Biochem Biophys Res Commun. 2004;321(1):65–71.
   PubMed Web of Science ®Google Scholar
• Kielczewski JL, Jarajapu YP, McFarland EL, et al. Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation. Circ Res. 2009;105:897–905.
   PubMed Web of Science ®Google Scholar
• Anderson EM, Kwee BJ, Lewin SA, et al. Local delivery of VEGF and SDF enhances endothelial progenitor cell recruitment and resultant recovery from ischemia. Tissue Engineering: Part A. 2015;21:1217–1227.
   PubMed Web of Science ®Google Scholar
• Dewland TA, Vittinghoff E, Harris TB, et al. Inflammation as a mediator of the association between race and atrial fibrillation: results from the health, aging, and body composition. Study JACC Clin Electrophysiol. 2015 Aug;1(4):248–255.
   PubMedGoogle Scholar
• Polovina M, Ostojic MC, Potpara TS, et al. Relation of biomarkers of inflammation and oxidative stress with hypertension occurrence in lone atrial fibrillation. Mediators Inflamm. 2015;2015:653026.
   PubMed Web of Science ®Google Scholar
• Kusayama T, Furusho H, Kashiwagi H, et al. Inflammation of left atrial epicardial adipose tissue is associated with paroxysmal atrial fibrillation. J Cardiol. 2015;15:00371–00378.
   Google Scholar
• Cesari F, Marcucci R, Gori AM, et al. Impact of a cardiac rehabilitation program and inflammatory state on endothelial progenitor cells in acute coronary syndrome patients. Int J Cardiol. 2013;167(5):1854–1859.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang YT, Shang ZL, et al. Role of inflammation in the initiation and maintenance of atrial fibrillation and the protective effect of atorvastatin in a goat model of aseptic pericarditis. Mol Med Rep. 2015;11(4):2615–2623.
   PubMed Web of Science ®Google Scholar
• Chen A, He F, Cheng J, et al. Effect of C-reactive protein on notch pathway components in human periphery blood endothelial progenitor cells. Na Fang Yi Ke Da Xue. 2012;32:239–242.
   PubMedGoogle Scholar
• Fujii H, Li SH, Szmitko PE, et al. C-reactive protein alters antioxidant defenses and promotes apoptosis in endothelial progenitor cells. Arterioscler Thrombvasc Biol. 2006;26:2476–2482.
   PubMed Web of Science ®Google Scholar
• Berezin AE, Samura TA, Kremzer A, et al. An association of serum vistafin level and number of circulating endothelial progenitor cells in type 2 diabetes mellitus patients. Diabetes Metabo Syndr. 2016;10:205–212.
   PubMed Web of Science ®Google Scholar